A Phase 4 interventional study of etoricoxib in Acute Pain, sponsored by Hospital Padre Hurtado. Status unknown. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2009-07-08.
Sponsored by Hospital Padre Hurtado · Phase 4, Interventional, and Treatment
The purpose of the study is evaluate the analgesic efficacy and safety profile of the Cox-2 specific analgesic Etoricoxib (arcoxia®) when administrated pre and postoperatively for controlling pain in adult patients undergoing thyroid surgery. Patients will be followed up in the immediate postoperative period, during the first postoperative (POD) day and in POD 2, 3 and 7. It is expected that with the addition of Etoricoxib, patients will experience less pain during the overall postoperative period and also a better quality of recovery when compared with the traditional analgesic regimen.
876 studies on the registry are indexed under Acute Pain; 154 are open to participants now.
This study's planned enrollment of 70 is below the median of 90 across 732 interventional studies indexed under Acute Pain.
Browse Acute Pain studies →This is the only study on the registry with Hospital Padre Hurtado as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
G1 (CONTROL): Oral NSAID (diclofenac, three times a day) administrated pre-operatively and for 3 days after surgery. G2: Etoricoxib 120 mg, pre and post-operatively for 3 days after surgery
Drug: etoricoxib
G1 (CONTROL): Oral NSAID (diclofenac, three times a day) administrated pre-operatively and for 3 days after surgery. G2: Etoricoxib 120 mg, pre and post-operatively for 3 days after surgery
Maximum pain scores during postoperative period
Time frame: every 6 hours, 24hours,48hours,72hours.
Total amount of rescue analgesics
Time frame: 24hours, 48hours, 72hours.
No study locations are listed for this record.
This study is status unknown, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.